Get Your Clinical Trial Studies Right the First Time Around

This has been quite a year, since October we’ve watched global markets falter, a new president get elected and sweeping healthcare reform is being debated on the floors of congress. All this is impacting the pharmaceutical industry and companies are responding by aggressively reducing costs and how to get better results from all of their outsourced clinical research. We know you’re feeling the pressure rise as the volume of outsourced work continues to increase. In order to design a process that will save time in the long run it is important to have a firm grounding in the fundamentals.

For 2009 Fundamentals of Clinical Outsourcing has been updated with timely topics, in-depth roundtable discussions and increased networking opportunities to create a highly focused learning opportunity that will help you better manage your outsourcing partners and expedite clinical trials.

New for 2009!
• Keynote presentation from Ken Getz, Senior Research Fellow from the Tufts Center for the Study of Drug Development on tracking the transition from transaction to portfolio based relationships
• Genzyme and Milennium executives discuss relationship management and The Rules of Engagement
• FDA address from Michael Marcarelli the Director of the Office of Bioresearch Monitoring at CDRH tells participants what the FDA Expects regarding quality oversight of third parties

If you are ready to send a new compound into clinical development and you don’t have the in-house resources to execute the trial or if you are overwhelmed by the choices that need to be made every day to keep your products moving through development, Fundamental of Clinical Outsourcing is your best opportunity to obtain best practices, set your outsourcing strategy and manage successful relationships with proven rules of engagement.

Download the brochure today, and then visit the website to reserve your seat! I look forward to seeing you there.

5th Annual Fundamentals of Clinical Outsourcing East

This has been quite a year, since October we’ve watched global markets falter, a new president get elected and sweeping healthcare reform is being debated on the floors of congress. All this is impacting the pharmaceutical industry and companies are responding by aggressively reducing costs and how to get better results from all of their outsourced clinical research. We know you’re feeling the pressure rise as the volume of outsourced work continues to increase. In order to design a process that will save time in the long run it is important to have a firm grounding in the fundamentals.

For 2009 Fundamentals of Clinical Outsourcing has been updated with timely topics, in-depth roundtable discussions and increased networking opportunities to create a highly focused learning opportunity that will help you better manage your outsourcing partners and expedite clinical trials.

New for 2009!
• Keynote presentation from Ken Getz, Senior Research Fellow from the Tufts Center for the Study of Drug Development on tracking the transition from transaction to portfolio based relationships
• Genzyme and Milennium executives discuss relationship management and The Rules of Engagement
• FDA address from Michael Marcarelli the Director of the Office of Bioresearch Monitoring at CDRH tells participants what the FDA Expects regarding quality oversight of third parties

If you are ready to send a new compound into clinical development and you don’t have the in-house resources to execute the trial or if you are overwhelmed by the choices that need to be made every day to keep your products moving through development Fundamental of Clinical Outsourcing is your best opportunity to obtain best practices, set your outsourcing strategy and manage successful relationships with proven rules of engagement.

Download the agenda to see all the new updates to the 2009 event.

Start the conversations now:
Join the LinkedIn Group!
Follow us on Twitter!

How to find the best cost-effective treatments

According to Red Orbit, Congress has allotted $1.1 billion to begin finding the best treatments for certain ailments that are also cost-effective. A report came out addressing the top 100 medical issues addressed by Congress. The report said this of clinical trials:

“Clinical research provides health care providers with information on the natural history of disease, clinical presentations of disease, and diagnostic and treatment options,” according to the report.

“All too often, the information necessary to inform these medical decisions is incomplete or unavailable, resulting in more than half of the treatments delivered today without clear evidence of effectiveness.

“This uncertainty contributes to great variability in managing clinical problems, with costs and outcomes differing markedly across the country.”